HR 4771 · 113th Congress 2013–2015, ended

Designer Anabolic Steroid Control Act of 2014

Latest action · Dec 18, 2014 Became Public Law No: 113-260.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 29, 2014
  2. Passed HouseSep 15, 2014
  3. Passed SenateDec 11, 2014
  4. To the PresidentDec 13, 2014
  5. Became lawDec 18, 2014Public Law 113-260

Summary

(This measure has not been amended since it was passed by the House on September 15, 2014. The summary of that version is repeated here.)

Designer Anabolic Steroid Control Act of 2014 - Amends the Controlled Substances Act to add specified substances to the list of those included within the definition of "anabolic steroid." Provides that a drug or hormonal substance (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that is not listed and that is derived from, or has a chemical structure substantially similar to, an anabolic steroid that is listed, shall be considered to be an anabolic steroid for purposes of such Act if it: (1) has been created or manufactured with the intent of producing a substance that either promotes muscle growth or otherwise causes a pharmacological effect similar to that of testosterone; or (2) has been, or is intended to be, promoted in any manner suggesting that consuming it will promote any pharmacological effect similar to that of testosterone.

Prohibits a substance from being considered to be a drug or hormonal substance for purposes of such Act if it is: (1) an herb or other botanical, a concentrate, metabolite, or extract of, or a constituent isolated directly from, an herb or other botanical, or a combination of two or more such substances; or (2) a dietary ingredient for purposes of the Federal Food, Drug, and Cosmetic Act and is not anabolic or androgenic. Requires any person claiming the benefit of such an exception to bear the burden of providing the appropriate evidence.

Authorizes the Attorney General to issue an order adding a drug or other substance to the definition of "anabolic steroid" upon finding that: (1) the substance satisfies the criteria for being considered an anabolic steroid, and (2) such addition will assist in preventing abuse or misuse of the substance.

Prohibits importing, exporting, manufacturing, distributing, dispensing, or possessing with intent to manufacture, distribute, or dispense any anabolic steroid, or any product containing an anabolic steroid, unless it bears a label clearly identifying the anabolic steroid by the nomenclature used by the International Union of Pure and Applied Chemistry (IUPAC). Prescribes penalties. Sets forth an exemption from such IUPAC nomenclature requirement if such product is labeled in the manner required under the Federal Food, Drug, and Cosmetic Act, as described in this Act.

Authorizes the Attorney General to: (1) collect data and analyze products to determine whether they contain anabolic steroids and are properly labeled, and (2) publish a list of products containing an anabolic steroid that are not properly labeled.

Cosponsors 6

Members who signed on, in the order they did. Signatures ran from May 29, 2014 to Jul 25, 2014; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
D-NJFrank Pallone, Jr.OriginalMay 29, 2014
R-UTJason ChaffetzJun 25, 2014
D-NMBen Ray LujánJul 8, 2014
D-NHCarol Shea-PorterJul 9, 2014
R-NVMark E. AmodeiJul 9, 2014
D-ILTammy DuckworthJul 25, 2014

Committees 3

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred May 29, 2014Markup Jul 15, 2014Reported Sep 15, 2014
Health Subcommittee
Referred May 30, 2014Markup Jun 19, 2014Reported Jun 19, 2014
HouseJudiciary Committee
Referred May 29, 2014Markup Sep 10, 2014Reported Sep 15, 2014
Crime and Federal Government Surveillance Subcommittee
Referred Jul 21, 2014Discharged Sep 9, 2014
SenateJudiciary Committee
Referred Sep 16, 2014Discharged Dec 12, 2014

Actions 28

Everything that happened, newest first.

  1. Dec 18, 2014Signed by President.
  2. Dec 18, 2014Became Public Law No: 113-260.
  3. Dec 13, 2014Presented to President.
  4. Dec 12, 2014Message on Senate action sent to the House.
  5. Dec 11, 2014Senate Committee on the Judiciary discharged by Unanimous Consent.(consideration: CR S6696)
  6. Dec 11, 2014Senate Committee on the Judiciary discharged by Unanimous Consent. (consideration: CR S6696)
  7. Dec 11, 2014Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
  8. Sep 16, 2014Received in the Senate and Read twice and referred to the Committee on the Judiciary.
  9. Sep 15, 2014Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-587, Part I.
  10. Sep 15, 2014Reported (Amended) by the Committee on Judiciary. H. Rept. 113-587, Part II.
  11. Sep 15, 2014Placed on the Union Calendar, Calendar No. 434.
  12. Sep 15, 2014Mr. Pitts moved to suspend the rules and pass the bill, as amended.
  13. Sep 15, 2014Considered under suspension of the rules. (consideration: CR H7459-7461)
  14. Sep 15, 2014DEBATE - The House proceeded with forty minutes of debate on H.R. 4771.
  15. Sep 15, 2014Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7459-7460)
  16. Sep 15, 2014Motion to reconsider laid on the table Agreed to without objection.
  17. Sep 10, 2014Committee Consideration and Mark-up Session Held.
  18. Sep 10, 2014Ordered to be Reported (Amended) by Voice Vote.
  19. Sep 9, 2014Subcommittee on Crime, Terrorism, Homeland Security, and Investigations Discharged.
  20. Jul 21, 2014Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
  21. Jul 15, 2014Committee Consideration and Mark-up Session Held.
  22. Jul 15, 2014Ordered to be Reported (Amended) by Voice Vote.
  23. Jul 14, 2014Committee Consideration and Mark-up Session Held.
  24. Jun 19, 2014Subcommittee Consideration and Mark-up Session Held.
  25. Jun 19, 2014Forwarded by Subcommittee to Full Committee by Voice Vote .
  26. May 30, 2014Referred to the Subcommittee on Health.
  27. May 29, 2014Introduced in House
  28. May 29, 2014Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In the Congressional Record 2

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
SenateDebate and remarks S6696Mark L. Pryor D-ARDec 11, 2014
HouseDebate and remarks H7459–H7461Text printed H7459Donna M. Christensen D-VI, Henry A. Waxman D-CA, Joseph R. Pitts R-PASep 15, 2014

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Congressional Budget Office cost estimates 2

  1. Sep 15, 2014H.R. 4771, Designer Anabolic Steroid Control Act of 2014As ordered reported by the House Committee on the Judiciary on September 10, 2014
  2. Jul 28, 2014H.R. 4771, Designer Anabolic Steroid Control Act of 2014As ordered reported by the House Committee on Energy and Commerce on July 15, 2014

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8, Clause 3, which states that Congress shall have the power ``to regulate commerce with foreign nations, and among the several states. . .''

The sponsor’s statement, as printed in the page H5023.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
Serial No. 113-109DRUG ENFORCEMENT ADMINISTRATION59 pagesJudiciary CommitteeSep 18, 2014

CRS reports 6

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 6

Products on other subjects that cite it, usually among other measures.

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 2012Designer Anabolic Steroid Control Act of 2014Related billFeb 11, 2014

Titles 5

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Controlled Substances Act to more effectively regulate anabolic steroids.
Short Titles as Introduced
Designer Anabolic Steroid Control Act of 2014
Short Titles as Passed House
Designer Anabolic Steroid Control Act of 2014
Short Titles as Passed Senate
Designer Anabolic Steroid Control Act of 2014
Short Titles as Enacted
Designer Anabolic Steroid Control Act of 2014

Subjects

Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.

Text 5

Each version as it was printed, newest first.

  1. —Enrolled Bill
  2. Sep 16, 2014Referred in Senate
  3. Sep 15, 2014Engrossed in House
  4. Sep 15, 2014Reported in House
  5. May 29, 2014Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.